The 4th GPCR-Targeted Drug Discovery Summit focuses on strategies for advancing GPCR-targeted drug discovery, including the use of advanced technology, ensuring drug selectivity, and expanding druggable GPCR targets.
Topics
How to employ advanced technology to streamline hit-to-lead generation of small molecules and biologics?
What is the GPCR commercial and investor opportunity?
How to ensure selectivity and potency of GPCRs-targeted drugs?
How to characterize the complex dynamic confirmations of GPCRs?
How to fast-track IND-filing & accelerate the progression of novel small molecule and biologic candidates into the clinic?
How can we comprehensively expand the repertoire of druggable GPCRs targets, including orphan GPCRs?
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.By clicking "Accept", you consent to our use of cookies. You can manage your preferences or learn more by clicking "Customize" or visiting our Cookies Policy page.
